Jazz Pharmaceuticals Completes $820 Million Upfront Acquisition of Actio Biosciences
MT newswire2026/09/15 14:16Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
10:16 AM EDT, 09/15/2026 (MT Newswires) -- Jazz Pharmaceuticals (JAZZ) has completed its acquisition of privately held Actio Biosciences for $820 million upfront, the company said Tuesday. The acquisition adds ABS-1230, a clinical-stage investigational therapy for KCNT1-related epilepsy, to Jazz Pharmaceuticals' pipeline. ABS-1230 is an oral, small-molecule KCNT1 inhibitor being developed for KCNT1-related epilepsy. Price: 244.75, Change: -1.12, Percent Change: -0.46
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Archer-Daniels-Midland to Enter Voluntary Carbon Removal Market With Nebraska Facility
MT newswire•2026/09/21 16:15
Frontier Lithium restructures convertible loan, cuts conversion price to $0.46
Bitget•2026/09/21 16:14
Co-Diagnostics joins global health roundtable on Ebola outbreak innovation
Bitget•2026/09/21 16:09
Crypto prices
MoreBitcoin
BTC
$85,901.37
+5.83%
Ethereum
ETH
$2,749.22
+4.82%
Tether USDt
USDT
$0.9999
+0.01%
BNB
BNB
$800.32
+5.45%
XRP
XRP
$1.5
+7.26%
USDC
USDC
$0.9998
-0.02%
Solana
SOL
$117.85
+8.24%
TRON
TRX
$0.3452
+0.21%
Zcash
ZEC
$1,494.46
+3.00%
Hyperliquid
HYPE
$93.11
+0.78%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now